Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Nutriband Inc. - Common Stock
(NQ:
NTRB
)
5.480
-0.250 (-4.36%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 23, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nutriband Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Nutriband Inc. (NASDAQ: NTRB) Near the Top of Equities by Percentage Gain on 5/31
May 31, 2023
Via
Investor Brand Network
Nutriband to Attend 2023 BIO International Convention
May 10, 2023
Via
ACCESSWIRE
Nutriband Earnings Perspective: Return On Capital Employed
May 04, 2023
Via
Benzinga
Nutriband Inc. Reports Revenue Up 46% in Fiscal 2023
April 27, 2023
Via
ACCESSWIRE
Nutriband Inc. to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023
April 19, 2023
Via
ACCESSWIRE
Nutriband With Kindeva Drug Delivery Select Aversa(TM) Fentanyl Abuse Deterrent Formulation for Commercial Scale Manufacturing Process Development
April 04, 2023
Via
ACCESSWIRE
Nutriband Inc. Commences Trading on Upstream Under NTRB
January 05, 2023
Via
ACCESSWIRE
Nutriband Inc. Will Be the First Company to Dual List on Upstream
December 30, 2022
Via
ACCESSWIRE
Nutriband Approved for Dual Listing on Upstream
December 14, 2022
Via
ACCESSWIRE
Nutriband Secures $2 Million Line of Credit Financing Facility to be Used for Commercialization of AVERSA(TM) Abuse-Deterrent Transdermal Technology
March 28, 2023
Via
ACCESSWIRE
Nutriband Inc Joins Webull Corporate Communications Service Platform
March 08, 2023
Via
ACCESSWIRE
Nutriband COO Alan Smith Ph.D. Selected for FDA Center for Research on Complex Generics Stakeholder Expert Committee
March 02, 2023
Via
ACCESSWIRE
Nutriband Inc. to File for Product Distribution Permit in South America with Ecuador's Health Register
February 15, 2023
Via
ACCESSWIRE
Nutriband Inc. to Present at the 2023 Transdermal and Microneedle Conference
January 24, 2023
Via
ACCESSWIRE
Nutriband Supports Newly Published CDC Opioid Prescribing Guidelines
November 08, 2022
Via
ACCESSWIRE
InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Begins New Year by Trading on Upstream
January 09, 2023
Via
Investor Brand Network
InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Starts Trading on Upstream
January 05, 2023
Via
Investor Brand Network
Nutriband Inc. to Officially Launch AI Tape brand in Q1 2023
December 29, 2022
Via
ACCESSWIRE
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Announces Approval to Dual List, to Commence Trading on Upstream
December 14, 2022
Via
Investor Brand Network
Nutriband Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
December 14, 2022
Via
ACCESSWIRE
Nutriband Inc. Reports Record Revenue Up 118% YoY in Q3
December 05, 2022
Via
ACCESSWIRE
Nutriband Inc to Participate at the RHK Capital Disruptive Growth Conference on December 5-6, 2022
December 02, 2022
Via
ACCESSWIRE
Nutriband Receives Notice of Issuance from the Canadian Intellectual Property Office for its AVERSA(TM) Abuse Deterrent Transdermal Technology Patent
December 01, 2022
Via
ACCESSWIRE
Nutriband To Manufacture Fleur Marché-Branded CBD Wellness Patches
October 27, 2022
Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW), has signed an exclusive manufacturing agreement with Fleur Marché for its CBD and Botanical Patch lines.
Via
Benzinga
Nutriband Inc. to Manufacture Fleur Marché-branded Wellness Patches Under Exclusive Agreement
October 27, 2022
Via
ACCESSWIRE
Nutriband Subsidiary, 4P Therapeutics LLC, Conducts Phase 1b Clinical Study for Sorrento Therapeutics, Inc. on Lymphatic Etanercept Delivery in Rheumatoid Arthritis Patients With Results To Be Presented at the 2022 American College of Rheumatology
October 26, 2022
Via
ACCESSWIRE
Nutriband Inc. Invited to Present at the 2023 Transdermal and Microneedle Conference in London on January 23 and 24
October 17, 2022
Via
ACCESSWIRE
Nutriband With Kindeva Drug Delivery Demonstrate Enhanced Abuse-Deterrent Characteristics for AVERSA(TM) Fentanyl
October 04, 2022
Via
ACCESSWIRE
Nutriband Inc. Announces Application for Dual Listing on Upstream
October 03, 2022
Via
ACCESSWIRE
Nutriband's Return On Capital Employed Insights
September 15, 2022
According to data from Benzinga Pro, during Q1, Nutriband's (NASDAQ:NTRB) reported sales totaled $477 thousand. Despite a 72.44% increase in earnings, the company posted a loss of $1.04 million.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.